Funding Cuts Halt Access to PrEP for Millions, Threatening Global HIV Prevention Efforts

Significant funding reductions have disrupted access to pre-exposure prophylaxis (PrEP) for millions of individuals, impacting global HIV prevention efforts. The World Health Organization (WHO) has reported that these cuts have stalled progress in preventing the spread of HIV, leaving many vulnerable populations without critical preventative care.

The WHO’s chief confirmed that the loss of PrEP access is a direct result of sharp financial cutbacks, which have affected programs aimed at reducing new HIV infections. PrEP, a medication taken to prevent HIV transmission, has been a cornerstone in global public health strategies targeting high-risk groups. However, with reduced funding, many regions are now struggling to maintain distribution and accessibility. This development raises concerns about reversing gains made in combating the virus and protecting at-risk communities worldwide.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

Related posts:

Patent Expirations on Blockbuster Drugs Trigger Generic Surge and Market Adaptation FDA Grants Priority Review to Sevabertinib for HER2-Mutated Advanced NSCLC Treatment Razer Core X V2 Introduced as Thunderbolt 3 External GPU Dock for Handheld Gaming Devices Study Finds Altered Brain Development in Infants with Congenital Sensorineural Hearing Loss

Author

GOAI